Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132305) titled 'A Study on the Impact of Switching to a New Smart Electronic Injection Pen on Compliance, Preference, and Efficacy in Children Receiving Growth Hormone Therapy' on Sept. 11.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Peking University First Hospital
Condition:
Various growth disorders such as growth hormone deficiency and idiopathic short stature
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-12
Target Sample Size: Switch to the intelligent electronic injection pen group:100;
Countries of Recruitment:
China
To know more, visit https...